Literature DB >> 15466941

The cellular fate of glucose and its relevance in type 2 diabetes.

Clara Bouché1, Shanti Serdy, C Ronald Kahn, Allison B Goldfine.   

Abstract

Type 2 diabetes is a complex disorder with diminished insulin secretion and insulin action contributing to the hyperglycemia and wide range of metabolic defects that underlie the disease. The contribution of glucose metabolic pathways per se in the pathogenesis of the disease remains unclear. The cellular fate of glucose begins with glucose transport and phosphorylation. Subsequent pathways of glucose utilization include aerobic and anaerobic glycolysis, glycogen formation, and conversion to other intermediates in the hexose phosphate or hexosamine biosynthesis pathways. Abnormalities in each pathway may occur in diabetic subjects; however, it is unclear whether perturbations in these may lead to diabetes or are a consequence of the multiple metabolic abnormalities found in the disease. This review is focused on the cellular fate of glucose and relevance to human type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15466941     DOI: 10.1210/er.2003-0026

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  108 in total

Review 1.  Cardiac metabolic adaptations in response to chronic hypoxia.

Authors:  M Faadiel Essop
Journal:  J Physiol       Date:  2007-08-30       Impact factor: 5.182

2.  Dynamic O-linked N-acetylglucosamine modification of proteins affects stress responses and survival of mesothelial cells exposed to peritoneal dialysis fluids.

Authors:  Rebecca Herzog; Thorsten O Bender; Andreas Vychytil; Katarzyna Bialas; Christoph Aufricht; Klaus Kratochwill
Journal:  J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 10.121

3.  The hexosamine biosynthesis pathway is essential for pancreatic beta cell development.

Authors:  Gaëlle Filhoulaud; Ghislaine Guillemain; Raphaël Scharfmann
Journal:  J Biol Chem       Date:  2009-07-07       Impact factor: 5.157

4.  Molecular characterization, chromosomal location, alternative splicing and polymorphism of porcine GFAT1 gene.

Authors:  K Liu; G Wang; S H Zhao; B Liu; J N Huang; X Bai; M Yu
Journal:  Mol Biol Rep       Date:  2009-09-13       Impact factor: 2.316

Review 5.  Modulation of transcription factor function by O-GlcNAc modification.

Authors:  Sabire Ozcan; Sreenath S Andrali; Jamie E L Cantrell
Journal:  Biochim Biophys Acta       Date:  2010-03-02

6.  The role of dysregulated glucose metabolism in epithelial ovarian cancer.

Authors:  L D Kellenberger; J E Bruin; J Greenaway; N E Campbell; R A Moorehead; A C Holloway; J Petrik
Journal:  J Oncol       Date:  2010-02-17       Impact factor: 4.375

7.  Exposure to high or low glucose levels accelerates the appearance of markers of endothelial cell senescence and induces dysregulation of nitric oxide synthase.

Authors:  Steven C Rogers; Xiaomin Zhang; Gohar Azhar; Shaoke Luo; Jeanne Y Wei
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-04-12       Impact factor: 6.053

8.  Farnesoid X receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytes.

Authors:  Sandrine Caron; Carolina Huaman Samanez; Hélène Dehondt; Maheul Ploton; Olivier Briand; Fleur Lien; Emilie Dorchies; Julie Dumont; Catherine Postic; Bertrand Cariou; Philippe Lefebvre; Bart Staels
Journal:  Mol Cell Biol       Date:  2013-03-25       Impact factor: 4.272

9.  O-GlcNAc Modification: Friend or Foe in Diabetic Cardiovascular Disease.

Authors:  Udayakumar Karunakaran; Nam Ho Jeoung
Journal:  Korean Diabetes J       Date:  2010-08-31

10.  Phasing of muscle gene expression with fasting-induced recovery growth in Atlantic salmon.

Authors:  Neil I Bower; Richard G Taylor; Ian A Johnston
Journal:  Front Zool       Date:  2009-08-24       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.